{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:41Z","timestamp":1786995461643,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.parkreldis.2021.03.017","type":"journal-article","created":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T17:28:02Z","timestamp":1616952482000},"page":"5-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8579-3772","authenticated-orcid":false,"given":"Carlo Alberto","family":"Artusi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Romagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Imbalzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Montanaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Zibetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Giorgio","family":"Rizzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Lopiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parkreldis.2021.03.017_bib1","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mds.25844","article-title":"Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease","volume":"29","author":"Berg","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson's disease: clinical features and diagnosis","volume":"79","author":"Jankovic","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.parkreldis.2016.04.026","article-title":"Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease","volume":"28","author":"Erro","year":"2016","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib4","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease","volume":"76","author":"De Pablo-Fern\u00e1ndez","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1474-4422(08)70291-6","article-title":"Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease","volume":"8","author":"Benabid","year":"2009","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneurol.2010.260","article-title":"Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues","volume":"68","author":"Bronstein","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1136\/jnnp.72.1.53","article-title":"Deep brain stimulation of the subthalamic nucleus: anatomical, neurophysiological, and outcome correlations with the effects of stimulation","volume":"72","author":"Lanotte","year":"2002","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/1531-8257(199907)14:4<572::AID-MDS1005>3.0.CO;2-C","article-title":"Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD)","volume":"14","author":"Defer","year":"1999","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib10","first-page":"153","article-title":"Members of the UPDRS development committee, the unified parkison's disease rating scale","volume":"vol. 2","author":"Fahn","year":"1987"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-510X(01)00575-5","article-title":"Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: comparison of pre- and postoperative neuropsychological evaluation","volume":"192","author":"Perozzo","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib12","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/mds.25175","article-title":"NINDS NET-PD investigators, design innovations and baseline findings in a long-term Parkinson's trial: the national institute of neurological disorders and stroke exploratory trials in Parkinson's disease long-term study-1","volume":"27","author":"Elm","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib13","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib14","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/mds.23907","article-title":"Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?","volume":"26","author":"Daniels","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib15","doi-asserted-by":"crossref","first-page":"e1109","DOI":"10.1212\/WNL.0000000000007037","article-title":"Quality of life predicts outcome of deep brain stimulation in early Parkinson disease","volume":"92","author":"Schuepbach","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib16","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.brs.2018.02.015","article-title":"EUROPAR and the IPMDS Non Motor PD Study Group, Short-term quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson's disease","volume":"11","author":"Dafsari","year":"2018","journal-title":"Brain Stimul"},{"key":"10.1016\/j.parkreldis.2021.03.017_bib17","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa060281","article-title":"German Parkinson Study Group, Neurostimulation Section, A randomized trial of deep-brain stimulation for Parkinson's disease","volume":"355","author":"Deuschl","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.parkreldis.2021.03.017_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.7800","article-title":"Association of subthalamic deep brain stimulation with motor, functional, and pharmacologic outcomes in patients with monogenic Parkinson disease: a systematic review and meta-analysis","volume":"2","author":"Artusi","year":"2019","journal-title":"JAMA Netw. Open."}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:35Z","timestamp":1761178895000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":18,"alternative-id":["S1353802021001103"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.017","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}